Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02370797 · ClinicalTrials.gov registry record · NA

Node Negative, Invasive Breast Cancer Single Fraction IOERT

A NA study of Breast Cancer, sponsored by Avera McKennan Hospital & University Health Center.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02370797: Active NA study of Breast Cancer, sponsored by Avera McKennan Hospital & University Health Center.

NCT02370797 is a NA study of Breast Cancer that is active but no longer recruiting, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02370797, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Avera McKennan Hospital & University Health Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if lumpectomy followed by Intraoperative Electron Radiation Therapy (IOeRT) as a single, full dose partial breast irradiation will have as good or better results in preventing recurrence of local breast cancer, cosmetic appearance and early and late side effects.

Primary Outcome

Patients will be followed by standard of care breast imaging along with appointments with breast surgeon, radiation oncologist and medical oncologist if indicated.

Conditions Studied

Interventions

  • RADIATION Single Fraction IOeRT

Study Locations (1)

South Dakota

  • Avera Cancer Institute - Sioux Falls

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-02
Est. Completion 2029-05
Phase NA

What the registry record for NCT02370797 still lists

NCT02370797 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Single Fraction IOeRT is the first listed.

NCT02370797 reports a single indexed study location in South Dakota.

Frequently Asked Questions

What is clinical trial NCT02370797 about?

NCT02370797 is a clinical study titled "Node Negative, Invasive Breast Cancer Single Fraction IOERT". The purpose of this study is to determine if lumpectomy followed by Intraoperative Electron Radiation Therapy (IOeRT) as a single, full dose partial breast irradiation will have as good or better results in preventing recurrence of local breast cancer, cosmetic appearance and early and late side eff...

What is the current status of trial NCT02370797?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2015-02. Estimated completion is 2029-05.

What conditions does trial NCT02370797 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02370797?

The interventions under investigation include: Single Fraction IOeRT (RADIATION).

Who is sponsoring clinical trial NCT02370797?

This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02370797 being conducted?

This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02370797's enrollment target sits among peer trials

100 565th of 1224 higher than 630 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02370797, the US trial registry maintained by the National Library of Medicine. NCT02370797 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.